Anti-Inflammatory Substances of Plant Origin

  • M. Gábor
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 50 / 2)


Until recently, information on anti-inflammatory agents of plant origin was sparse. The first reviews dealt primarily with the phenylbenzo-γ-pyrones (flavonoids) (Gábor, 1972 a, 1975); however, there are other substances of plant origin with antiinflammatory action. Although these are not as potent as the non-steroid antiinflammatory agents knowledge of the structure activity relationships may lead to newer and more effective preparations.


Plant Origin Glycyrrhetinic Acid Histidine Decarboxylase Cotton Pellet Berberine Chloride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akhter, M.H., Sabir, M., Bhide, N.K.: Anti-inflammatory effect of berberine in rats injected locally with cholera toxin. Indian J. Med. Res. 65, 133–141 (1977)PubMedGoogle Scholar
  2. Andersen, N.H., Ramwell,P.W.: Biological aspects of prostaglandins. Arch, intern. Med. 133, 30–50(1974)Google Scholar
  3. Antal, A., Gábor, M.: UV erythema értékelésére szolgáló késziilék (Apparat für die Bewertung des UV-Erythems). Kisérl. Orvostud. 23, 478–481 (1971). Cited in: Gábor, M.: The Anti-Inflammatory Action of Flavonoids. Budapest: Akadémiai Kiadó 1972Google Scholar
  4. Armentano, L., Bentsáth, A., Béres, T., Rusznyák, St., Szent-Györgyi, A.: Über den Einfluß von Substanzen der Flavongruppe auf die Permeabilität der Kapillaren. Vitamin P. Dtsch. med. Wschr. 62, 1325–1328 (1936)Google Scholar
  5. Arnold, W.: Über Kamille, Pfefferminze und Fenchel. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 123, 129–159 (1927)Google Scholar
  6. Arora, S., Lahiri, P.K., Sanyal, R.K.: The role of Prostaglandin E1 in inflammatory process in the rat. Int. Arch. Allergy 39, 186–191 (1970)PubMedGoogle Scholar
  7. Ascher, P.W.: Untersuchung der Pharmakodynamik und Pharmakokinetik des Aescins am Beispiel des Hirnödems. Wien. med. Wschr. 118, 1050–1051 (1968)PubMedGoogle Scholar
  8. Back, N., Sicuteri, F. (Eds.): Vasopeptides: Chemistry, Pharmacology, and pathophysiology. Proceedings of the Symposium on Vasopeptides. Florence, Italy, 1971. New York-London: Plenum Press 1972Google Scholar
  9. Baeckeland, E., Lecomte, J.: Dérivés hydroxyetilés du rutoside isolés du rat. C.R. Soc. Biol. (Paris) 163, 2226–2229(1969)Google Scholar
  10. Bartlett, G.R.: Inhibition of succinoxydase by the vitamin P-like flavonoid 2′,3,4-trihydroxy chalcone. J. Pharmacol, exp. Ther. 93, 329–337 (1948)Google Scholar
  11. Beitch, B.R., Eakins, K. E.: The effects of prostaglandins on the intraocular pressure of the rabbit. Brit. J. Pharmacol. 37, 158–167 (1969)Google Scholar
  12. Bogs, U., Meinhard, J.: Zur Herstellung von Kamillen-Fluidextrakt. Pharmazie 10, 653–658 (1955)PubMedGoogle Scholar
  13. Böhm, K.: The Flavonoids. A Review of Their Physiology, Pharmacodynamics and Therapeutic Uses. Aulendorf, Württ.: Editio Cantor KG. 1968Google Scholar
  14. Bonta, I.L.: Microvascular lesions as a target of anti-inflammatory and certain other drugs. Acta physiol. Pharmacol, neerl. 15, 188–222 (1969)Google Scholar
  15. Breinlich, J., Scharnagel, K.: Pharmakologische Eigenschaften des EN-IN-Dizykloäthers aus Matricaria chamomilla. Arzneimittel-Forsch. 18, 429–431 (1968)Google Scholar
  16. Brock, N., Kottmeier, J., Lorenz, D., Veigel, H.: Zur Frage der antiphlogistischen Wirkung von Azulenen im Tierversuch. Ein Beitrag zur Prüfungsmethodik entzündungswidriger Substanzen. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 223, 450–464 (1954)Google Scholar
  17. Bundy, G., Lincoln, F., Nelson, N., Pike, J., Schneider, W.: Novel prostaglandin syntheses. Ann. N.Y. Acad. Sci. 180, 76–90 (1971)PubMedGoogle Scholar
  18. Casley-Smith, J.R.: The actions of the benzo-pyrones on the blood-tissue-lymph-system. Folia Angiol. 24, 7–22(1976)Google Scholar
  19. Casley-Smith, J., Piller, N.B.: The pathogenesis of oedemas, and the therapeutic action of coumarin and related compounds. In: Foldi, M. (Ed.): Folia angiologica Supplementa, Basic Lymphology, Second Ringelheim Symposion, Vol.III, pp.33–59. Berlin-Wien: Haupt & Koska HG. 1974Google Scholar
  20. Chang, Y.-H.: Mechanism of action of colchicine. I. Effects of colchicine and its analogs on the reversed passive Arthus reaction and the carragenan-induced hindpaw edema in the rat. J. Pharmacol. exp. Ther. 194, 154–158 (1975a)PubMedGoogle Scholar
  21. Chang, Y.-H.: Mechanism of action of colchicine. II. Effect of colchicine and its analogs on phagocytosis and Chemotaxis in vitro. J. Pharmacol. exp. Ther. 194, 159–164 (1975 b)PubMedGoogle Scholar
  22. Chang, Y.-H.: III. Anti-inflammatory effects of colchicine compared with phenylbutazone and indomethacin. Arthritis Rheum. 18, 493–496 (1975 c)PubMedGoogle Scholar
  23. Chaturvedi, G.N., Singh, R.H.: Experimental studies on the anti-arthritic effect of certain indigenous drugs. Indian J. med. Res. 53, 71–80 (1965)PubMedGoogle Scholar
  24. Chaturvedi, A.K., Parmar, S.S., Bhatnagar, S.C., Misra, G., Nikam, S.K.: Anticonvulsant and anti-inflammatory activity of natural plant coumarins and triterpenoids. Res. Commun, chem. path. Pharmacol. 9, 11–22 (1974)Google Scholar
  25. Chaturvedi, A.K., Parmar, S.S., Nigam, S.K., Bhatnagar, S.C., Misra, G., Sastry, B.V.R.: Anti-inflammatory and anticonvulsant properties of some natural plant triterpenoids. Pharmacol. Res. Commun. 8, 199–210 (1976)PubMedGoogle Scholar
  26. Chau, T.T., Haley, T.J.: Flavonoid antagonism of the spasmogenic effect of angiotensin, bradykinin and eledoisin of guinea pig ileum. J. pharm. Sci. 58, 621–623 (1969)PubMedGoogle Scholar
  27. Chayen, J., Bitensky, L.: Lysosomal enzymes and inflammation with particular reference to rheumatoid diseases. Ann. rheum. Dis. 30, 333–405 (1969)Google Scholar
  28. Chevillard, L., Ranson, M., Senault, B.: Activité anti-inflammatoire d’extraits de fragon épineux (Ruscus aculeatus L.). Méd. Pharmacol. exp. 12, 109–114 (1965)Google Scholar
  29. Courbat, P.: Quelques généralités sur les composés flavonoïdes. In: Clinical Pharmacology: Flavonoids and vascular wall. Symposia angiologica Santoriana, 4 th International Symposium, Fribourg-Nyon, 1972, pp.3–29. Basel-München-Paris-London-New York-Sydney: S. Karger 1972Google Scholar
  30. Courbat, P., Favre, J., Guerne, R., Uhlmann, G.: Contribution à l’étude d’un produit de β-hydro-xyéthylation du rutoside. Partie 1. Isolement et identification des constituants majeurs par Chromatographie sur papier. Helv. chim. Acta 49, 1203–1211 (1966 a)Google Scholar
  31. Courbat, P., Uhlmann, G., Guerne, R.: Contribution à l’étude d’un produit de β-hydroxyéthylation du rutoside. Identification des constituants majeurs par spectrophotométrie ultraviolette. Helv. chim. Acta 49, 1420–1424 (1966 b)Google Scholar
  32. Crutchley, D.J., Piper, P.J.: Inhibition of the inactivation of prostaglandins in guinea pig lungs. Naunyn-Schmiedebergs Arch. Pharmacol. 279, 27 (1973)Google Scholar
  33. Dale, H.H., Laidlaw, P.P.: The physiological action of β-iminazolylethylamine. J. Physiol. (Lond.) 41, 318–344(1910)Google Scholar
  34. D’Arcy, P.F, Kellett, D.N.: Glycyrrhetinic acid. Brit. med. J. 1, 647 (1957)Google Scholar
  35. Dean, F.M.: Naturally occuring oxygen ring compounds. London: Butterworths 1963Google Scholar
  36. Denko, C.W., Whitehouse, M.W.: Effects of colchicine in rats with urate crystal-induced inflammation. Pharmacology (Basel) 3, 229–242 (1970)Google Scholar
  37. Dhawan, B.N., Srimal, R.C: Anti-inflammatory and some other pharmacological effects of 3,4-trans–2,2-dimethyl-3-phenyl-4-[p-(β-pyrrolidinoethoxy)-phenyl]-7-methoxy-chroman (Centchroman) Brit. J. Pharmacol. 49, 64–73 (1973)Google Scholar
  38. Diczfalusy, E., Fernö, O., Fex, H., Högberg, B., Linderot, T., Rosenberg, Th.: Synthetic high molecular weight enzyme inhibitors. I. Polymeric phosphates of phloretin and related compounds. Acta chem. scand. 7, 913–920 (1953)Google Scholar
  39. Dingle, J.T., Fell, H.B. (Eds.): Lysosomes in Biology and Pathology. Amsterdam: North-Holland 1969Google Scholar
  40. Doll, R., Hill, I.D., Hutton, C., Underwood, D.J.: Clinical trial of a triterpenoid liquorice compound in gastric and duodenal ulcer. Lancet II, 793 (1962)Google Scholar
  41. Eakins, K.E.: Prostaglandin antagonism by polymeric phosphates of phloretin and related compounds. Ann. N.Y. Acad. Sci. 180, 386–395 (1971)PubMedGoogle Scholar
  42. Eakins, K. E., Karim, S. M. M.: Polyphloretinphosphate–a selective antagonist for prostaglandin F1α and F2αLife Sci. 9, 1–5 (1970)PubMedGoogle Scholar
  43. Eakins, K.E., Karim, S.M.M., Miller, J.D.: Antagonism of some smooth muscle reactions of prostaglandins by polyphloretin phosphate—a selective antagonist for prostaglandins F1α and F2α. Life Sci. 9, 1–5 (1970)PubMedGoogle Scholar
  44. Eakins, K.E., Miller, J.D., Karim, M.M.: The nature of the prostaglandin-blocking activity of polyphloretin phosphate. J. Pharmacol. exp. Ther. 176, 441–447 (1971)PubMedGoogle Scholar
  45. Eakins, K.E., Sanner, J.H.: Prostaglandin antagonists. In: Karim, S.M.M. (Ed.): The Prostaglandins, pp.263–292. New York: Wiley-Interscience 1972Google Scholar
  46. Erdös, E.G.: Effect of nonsteroidal anti-inflammatory drugs in endotoxin shock. Biochem. Pharmacol. Suppl., 283–291 (1968)Google Scholar
  47. Erspamer, V. (Ed.): 5-Hydroxytryptamine and Related Indolealkylamines. Handbook experimental Pharmakology. Berlin-Heidelberg-New York: Springer 1966Google Scholar
  48. Farkas, L., Gábor, M., Kallay, F. (Eds.): Topics in Flavonoid Chemistry and Biochemistry. Proceedings of the Fourth Hungarian Bioflavonoid Symposium Keszthely, 1973. Budapest: Akadémiai Kiadö 1975Google Scholar
  49. Fassbender, H.G., Pippert, H.K.: Die allergisch-hyperergische Entzündung von Haut und Gelenken unter dem Einfluß von Hyaluronidase und Rutin. Z. ges. exp. Med. 123, 210–218 (1954)Google Scholar
  50. Felix, W.: Wirkungsmechanismus der internen Therapie mit „Venopharmaka“. Dtsch. med. Wschr. 21, 456–466 (1970)Google Scholar
  51. Feuer, G.: The metabolism and biological actions of Coumarins. In: Ellis, G.P., West, G.B. (Eds.): Progress in Medicinal Chemistry, Vol. 10, pp.85–158. Amsterdam-London: North-Holland 1974Google Scholar
  52. Finney, R.S.H., Somers, G.F.: The anti-inflammatory activity of glycyrrhetinic acid and derivatives. J. Pharm. (Lond.) 10, 613–620 (1958)Google Scholar
  53. Finney, R.S.H., Tarnoky, A.L.: The pharmacological properties of glycyrrhetinic acid hydrogen succinate (disodium salt). J. Pharm. (Lond.) 12, 49–58 (1960)Google Scholar
  54. Fitzgerald, T.J., Williams, B., Uyeki, E.H.: Colchicine on sodium urate-induced paw swelling in mice: structure-activity relationships of colchicine derivatives. Proc. Soc. exp. Biol. (N.Y.) 136, 115–120(1971)Google Scholar
  55. Flower, R.J.: Drugs which inhibit prostaglandin biosynthesis. Pharmacol. Rev. 26, 33–67 (1974)PubMedGoogle Scholar
  56. Földi, M., Zoltán, Ö.T.: Experimentelle Thrombophlebitis und deren therapeutische Beeinflussung. Arzneimittel-Forsch. 15, 901–903 (1965)Google Scholar
  57. Földi, M., Zoltán, Ö.T., Piukovich, I.: Die Wirkung von Rutin und Cumarin auf den Verlauf einer experimentellen Thrombophlebitis. Arzneimittel-Forsch. 20, 1629–1635 (1970)Google Scholar
  58. Földi-Börcsök, E.: Effect of external lymph drainage and of coumarin treatment injury in the rat hind leg. Brit. J. Pharmacol. 46, 254–259 (1972)Google Scholar
  59. Földi-Börcsök, E., Bedall, F.K., Rahlfs, V.W.: Die antiphlogistische und ödemhemmende Wirkung von Cumarin aus Melilotus officinalis. Arzneimittel-Forsch. 21, 2025–2030 (1971)Google Scholar
  60. Fontaine, L., Grand, M., Molho, D., Boschetti, E.: Activité anti-inflammatoire expérimentale de coumarins, indane-diones et acyl-indan-diones apparentées aux anticoagulants oraux. Méd. Pharmacol. exp. 17, 497–507 (1967)Google Scholar
  61. Formanek, K., Holler, H.: Über den Einfluß von Trioxyäthylrutin auf das experimentell erzeugte Ödem der Rattenpfote. Wien. med. Wschr. 110, 697–699 (1960)PubMedGoogle Scholar
  62. Fries, B.: The edema-inhibiting action of polyphloretin-phosphate (PPP) in some types of capillary damage. An experimental investigation. Acta chir. scand. 119, 1–7 (1960)PubMedGoogle Scholar
  63. Frimmer, M.: Biochemie und Pathophysiologie von Entzündungsmediatoren. Int. Z. klin. Pharmakol. Ther. Toxikol. 2, 144–151 (1971)Google Scholar
  64. Gábor, M.: The Anti-Inflammatory Action of Flavonoids. Budapest: Akadémiai Kiadó 1972aGoogle Scholar
  65. Gábor, M.: Pharmacologie effects of flavonoids on blood vessels. In: Comèl, M., Laszt, L. (Eds.): Clinical Pharmacology: Flavonoids and Vascular Wall. Symposia angiologica santoriana. 4 th International Symposium, Fribourg-Nyon 1972. Basel-München-Paris-London-New York-Sydney: Karger 1972bGoogle Scholar
  66. Gabor, M.: Influence of flavonoids on decrease of capillary resistance in inflammation caused by red paprika (Capsicum annuum L. Solanaceae). In: Gábor, M.: The Anti-Inflammatory Action of Flavonoids, pp.78–83. Budapest: Akadémiai Kiadó 1972 cGoogle Scholar
  67. Gábor, M.: Pathophysiology and Pharmacology of Capillary Resistance. Budapest: Akadémiai Kiadó 1974Google Scholar
  68. Gábor, M.: Abriß der Pharmakologie von Flavonoiden unter besonderer Berücksichtigung der antiödematösen und antiphlogistischen Effekte. Budapest: Akadémiai Kiadó 1975Google Scholar
  69. Gábor, M., Antal, A.: Influence of O-(β-hydroxyethyl)rutin on erythema induced by UV radiation. In: Gábor, M.: The Anti-Inflammatory Action of Flavonoids, pp.84–93. Akadémiai Kiadó 1972Google Scholar
  70. Gábor, M., Blazsö, G.: In: Gábor, M.: Abriß der Pharmakologie von Flavonoiden, unter besonderer Berücksichtigung der antiödematösen und antiphlogistischen Effekte. Budapest: Akadémiai Kiadö 1975Google Scholar
  71. Gábor, M., Iván, J.: Effect of O-(β-hydroxyethyl)rutin on the oedema-preventing action of butazolidin. In: Gábor, M.: The Anti-Inflammatory Action of Flavonoids, pp.94–100. Budapest: Akadémiai Kiadó 1972Google Scholar
  72. Gábor, M., Szórády, J.: Die Beeinflussung der experimentellen Senfölentzündungen mit Hematoxylin. Acta physiol. Acad. Sci. hung. 3, 405–407 (1952)Google Scholar
  73. Gábor, M., Szórády, I., Dirner, Z.: The inhibiting effect of the members of the haematoxylin group on the action of histidin-decarboxylase. Acta physiol. Acad. Sci. hung. 3, 595–600 (1952)Google Scholar
  74. Ganesan, P.A., Karim, S.M.M.: Polyphloretin phosphate temporarily potentiates prostaglandin E2 on the rat fundus, probably by inhibiting PG-15-hydroxyde-hydrogenase. J. Pharm. (Lond.) 25, 229–233(1973)Google Scholar
  75. Garcia Lerne, J., Walaszek, E.J.: Antagonists of pharmacologically active peptides: effect on guinea pig ileum and inflammation. Pharmacologist 9, 242 (1967)Google Scholar
  76. Garcia Lerne, J., Walaszek, E.J.: Antagonists of pharmacologically active peptides. Effect on guinea pig ileum and inflammation. Pharmacology and the Future of Man, Proceedings 5 th International Congr. Pharmacology, San Francisco 1972. Basel: Karger 1973, Vol.V, pp.328–335Google Scholar
  77. Garattini, S., Valzelli, L.: Serotonin. Amsterdam-London-New York: Elsevier 1965Google Scholar
  78. Gascon, A.L., Walaszek, E.J.: Inhibition of valyl5 angiotensinamide II by osajin. J. Pharm. (Lond.) 18, 478–479 (1966)Google Scholar
  79. Gecse, Á., Zsilinszky, N., Horpácsy, G., Gabor, M.: Data on the mechanism of the anti-inflammatory effect of flavonoids. In: Gábor, M.: The Anti-Inflammatory Action of Flavonoids. Budapest: Akadémiai Kiadó 1972Google Scholar
  80. Geissman, T.A.: The Chemistry of Flavonoid Compounds. Oxford-London-New York-Paris: Pergamon Press 1962Google Scholar
  81. Goldyne, M.E.: Prostaglandins and cutaneous inflammation. J. invest. Derm. 64, 377–385 (1975)PubMedGoogle Scholar
  82. Goodman, L.S., Gilman, A.: The pharmacological basis of therapeutics, 4 th ed. London: McMillan 1971Google Scholar
  83. Gözsi, B., Kátó, L.: Balancing Mechanisms in Acute Inflammation. Montreal: Thérien Frères 1970Google Scholar
  84. Griffith, J.G.Jr., Krewson, Ch. F., Naghski, J.: Rutin and Related Flavonoids. Chemistry—Pharmacology-Clinical applications. Easton, Pa.: Mack Publ. Co. 1955Google Scholar
  85. Gross, F.: Unspezifische Beeinflussung entzündlicher Reaktionen. Schweiz. med. Wschr. 80, 697–701 (1950a)PubMedGoogle Scholar
  86. Gross, F.: Zur Auslösung und Beeinflussung der Oedembildung nach Injektion von Hühnereiweiß an der Ratte. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 211, 421–426 (1950 b)Google Scholar
  87. Gross, F., Meier, R.: Die Wirkung von synthetischen Antihistaminkörpern auf die Senfölchemosis am Kaninchenauge. Experientia (Basel) 4, 400–402 (1948)Google Scholar
  88. Gugler, R., Dengler, H.J.: Inhibition of human liver catechol-O-methyltransferase. Naunyn-Schmiedebergs Arch. Pharmakol. 276, 223–233 (1973)Google Scholar
  89. Gujral, M.L., Sareen, K., Tangri, K.K., Amma, M.K.P., Roy, A.K.: Anti-arthritic and anti-inflammatory activity of gum guggul (Balsamodendron mukul Hook). Ind. J. Physiol. Pharmacol. 4, 267–273 (1960)Google Scholar
  90. Gupta, M.B., Bhalla, T.N., Gupta, G.P., Mitra, C.R., Bhargava, K.P.: Anti-inflammatory activity of natural products. I. Triterpenoids. Eur. J. Pharmacol. 6, 67–70 (1969)Google Scholar
  91. Gupta, M.B., Bhalla, T.N., Gupta, G.P., Mitra, C.R., Bhargava, K.P.: Anti-inflammatory activity of taxifolin. Jap. J. Pharmacol. 21, 377–382 (1971)PubMedGoogle Scholar
  92. Gupta, M.B., Bhalla, T.N., Tangri, K.K., Bhargava, K.P.: Biochemical study of the anti-inflammatory activity of α- and β-amyrin acetate. Biochem. Pharmacol. 20, 401–405 (1971)PubMedGoogle Scholar
  93. Haagen-Smit, A. J.: Azulenes. In: Progress in the Chemistry of Organic Natural Products. Zechmeister, L. (Ed.). Wien: Springer-Verlag 1948, pp.40–71Google Scholar
  94. Hammersen, F.: The fine structure of different types of experimental edemas for testing the effect of vasoactive drugs demonstrated with a flavonoid. In: Comèl, M., Laszt, L. (Eds.): Clinical Pharmacology: Flavonoids and Vascular wall. Symposia angiologica santoriana. 4th. International Symposium, Fribourg-Nyon 1972, pp.194–222. Basel-München-Paris-London-New York-Sydney: Karger 1972Google Scholar
  95. Hammersen, F., Möhring, E.: Der Feinbau der Endstrombahn beim Dextran-Ödem und deren Beeinflussung durch HR. Fortschr. Med. 86, 925–927 (1968)Google Scholar
  96. Hammersen, F., Möhring, E.: Das Dextran-Ödem der Ratte als morphologisches Modell zur Prüfung gefäßaktiver Pharmaka. Dtsch. med. Wschr. 21, 472–478 (1970)Google Scholar
  97. Hammersen, F., Möhring, E.: Zum Feinbau enzymatisch bedingter Endothel- und Erythrozytenveränderungen (Phospholipase-Ödem) und deren Beeinflussung durch HR. Dtsch. med. Wschr. 23, 406–409 (1972)Google Scholar
  98. Hansel, R., Rimpler, H., Walther, K.: Ein lipophiles Flavon aus der Kamille (Matricaria chamomilla L.). Naturwissenschaften 53, 19 (1966)PubMedGoogle Scholar
  99. Harborne, J.B.: Comparative Biochemistry of the Flavonoids. London-New York: Academic Press 1967Google Scholar
  100. Harborne, J.B., Mabry, T. J., Mabry, Y.H., Eds.: The Flavonoids. London: Chapman & Hall 1975Google Scholar
  101. Hava, M., Janku, L: The pharmacology of camomile and juniper. Rev. Czech. Med. 3, 1–9 (1957)Google Scholar
  102. Heubner, W., Albath, W.: Über die entzündungswidrige Wirkung des Rein-Azulens aus Matricaria chamomilla L. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 192, 383–388 (1939)Google Scholar
  103. Heubner, W., Grabe, F.: Über die entzündungswidrige Wirkung des Kamillenöls. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 171, 329–339 (1933)Google Scholar
  104. Hikino, H., Taguchi, T., Fujimura, H., Hiramatsu, Y.: Antiinflammatory principles of Caesalpinia sappan wood and of Haematoxylon Campechianum wood. Planta Med. 31, 214–220 (1977)PubMedGoogle Scholar
  105. Hopf, G., Kaessmann, H.J., Pekker, I., Schäfer, E.A., Weber, H.G.: Experimentelle Untersuchungen der Beeinflussung des postoperativen Extremitätenödems am Hunde mit einem Cumarin-Präparat. Arzneimittel-Forsch. 21, 854–855 (1971)Google Scholar
  106. Hörhammer, L., Wagner, H., Salfner, B.: Neue Flavonglykoside aus der Kamille (Matricaria chamomilla L.). 3. Mitteilung über Compositen- und Papilionaceenflavone. Arzneimittel-Forsch. 13, 33–36 (1963)Google Scholar
  107. Horton, E.W.: Prostaglandins. Berlin-Heidelberg-New York: Springer Verlag 1972Google Scholar
  108. Isaac, O.: Fortschritte in der Kamillenforschung. Dtsch. Apoth.-Ztg. 114, 255–260 (1974)Google Scholar
  109. Isaac, O., Schimpke, H.: Alte und neue Erkenntnisse der Kamillenforschung. Mitt. dtsch. pharm. Ges. 35, 133–147, 157–170(1965)Google Scholar
  110. Jakovlev, V., Schlichtegroll, A.: Zur entzündungshemmenden Wirkung von (-)-α-Bisabolol, einem wesentlichen Bestandteil des Kamillenöls. Arzneimittel-Forsch. 19, 615–616 (1969)Google Scholar
  111. Jancsó, M.: Histamin: A reticulo-endotheliális sejtrendszer élettani aktivátora (Histamine, the biological activator of the reticuloendothelial cell system). Orv. Lapja 3, 1025–1030 (1947 a)Google Scholar
  112. Jancso, N.: Histamine as a physiological activator of the reticuloendothelial system. Nature (Lond.) 160, 227–228 (1947 b)Google Scholar
  113. Jancsó, M.: Idegi mechanizmusok szerepe a gyulladá sban. Orv. Hetil. 106, 289–296 (1965)PubMedGoogle Scholar
  114. Jeličić-Hadžović, J., Stern, P.: Azulene und Bradykinin. Arzneimittel-Forsch. 22, 1210–1211 (1972)Google Scholar
  115. Kaley, G., Weiner, R.: Prostaglandin E1: a potential mediator. Ann. N.Y. Acad. Sci. 180, 338–350 (1970)Google Scholar
  116. Karim, S.M.M., Ed.: The Prostaglandins. New York: Wiley — Interscience 1972Google Scholar
  117. Kátó, L., Gözsy, L.: Effets vasculaires des bioflavonoïdes chez le rat. Vie méd. 50, 33–42 (1969)Google Scholar
  118. Kellner, M., Kovách, A.G.B., Földi, M.: Über die antiphlogistische Wirkung des Melilotusex-traktes Esberiven. Arzneimittel-Forsch. 15, 326–328 (1961)Google Scholar
  119. Khadzay, Ya.I.: Biological properties and pharmacological activity of coumarins and furocumarins. Akad. Nauk SSSR, Ser.5, Rast. Syr’e 12, 25–30 (1965). See Chem. Abst. 64, 1185dGoogle Scholar
  120. Khadzay, Ya.I., Obolentseva, G.V., Serdyuk, A.D.: On the pharmacology of acacetine. Farmakol. i Toksikol. 32, 451–453 (1969)Google Scholar
  121. König, H.: Zur Chemie der Prostaglandine-Biogenese, Stoffwechsel, Totalsynthese. Klin. Wschr. 53, 1041–1048 (1975)PubMedGoogle Scholar
  122. Koshland, D.E. Jr.: Conformation changes at the active site during enzyme action. Fed. Proc. 23, 719–726(1964)PubMedGoogle Scholar
  123. Kraus, S.D.: Glycyrrhetinic acid—a triterpene with antioestrogenic and anti-inflammatory activity. J. Pharm. (Lond.) 12, 300–306 (1960)Google Scholar
  124. Kristen, G., Schmidt, W.: Kamille und Azulene. Pharmakologie — Therapie — Galenik. Mitt, dtsch. pharm. Ges. 27, 105–114 (1957)Google Scholar
  125. Küchle, H.J., Wegener, H.: Quantitative Untersuchungen über Wirksamkeit und Wirkungsstärke entzündungshemmender Substanzen. Z. ges. exp. Med. 118, 136–142 (1951)PubMedGoogle Scholar
  126. Kuznecova, G.A.: Naturally oecuring coumarins and furocoumarins. Nauka 1967Google Scholar
  127. Lavollay, J., Neumann, J.: Les substances actives contre la fragilité vasculaire. Expos. ann. Biochim. méd. 10, 59 (1949)Google Scholar
  128. Lecomte, J.: Pouvoir amino-libérateur des bioflavonoïdes chez le rat. C.R. Soc. Biol. (Paris) 165, 433–435(1971)Google Scholar
  129. Lecomte, J., Van Cauwenberge, H.: Le pouvoir amino-libérateur du quelques bioflavonoïdes chez le rat. In: Comèl, M., Laszt, L. (Eds.): Clinical Pharmacology: Flavonoids and Vascular Wall. Symposia angiologica santoriana, 4 th International Symposium, pp.179–193. Fribourg-Nyon 1972, Basel-München-Paris-London-New York-Sydney: Karger 1972Google Scholar
  130. Lecomte, J., Van Cauwenberge, H.: Sur quelques propriétés pharmacologiques du mono (O.β.hydroxy éthyl) 7 rutoside chez le rat. Arch. int. Pharmacodyn. 208, 317–327 (1974)Google Scholar
  131. Lespagnol, A., Lespagnol, Ch., Lesieur, D., Cazin, J.Cl., Cazin, M., Beerens, H., Romond, Ch.: Activités analgésique, antiinflammatoire et antimicrobienne des chalcones et dihydrochalcones dérivées de l’acide salicylique. Bull. Chim. thér. 365–369 (1972)Google Scholar
  132. Leuschner, F.: Über die perkutane Beeinflussung von experimentellen Ödemen und Gewebsschäden bei Ratten. 2nd Czechoslovak Congress of Internal Medicine; Pathogenesis and Therapy in Edema, Bratislava 1970Google Scholar
  133. Leuschner, F., Leuschner, A.: Über die perkutane Beeinflussung von experimentellen. Ödemen und Gewebeschäden bei Ratten. 56, 612–618 (1972)Google Scholar
  134. Lewis, G.P.: Kinins in inflammation and tissue injury. In: Bradykinin, Kallidin and Kallikrein. In: Erdös, E.G. (Ed.): Handbook of Experimental Pharmacology. Berlin-Heidelberg-New York: Springer Verlag 1970, Vol. XXV, pp. 516–530Google Scholar
  135. Lietti, A., Cristoni, A., Picci, M.: Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimittel-Forsch. Drug Res. 26, 829–832 (1976)Google Scholar
  136. Linde, H., Cramer, G.: (-)-α-Bisabolol and cis-2-[Hexadim-(2,4)-yliden]-l,6-dioxaspiro-[4,4]-no-nen-(3) in handelsüblichen Kamillen-Extrakten. Arzneimittel-Forsch. 22, 583–585 (1972)Google Scholar
  137. Logeman, W., Lauria, F., Tosolini, G.: Über Ketole der 18α- und 18β-Glycyrrhetinsäure. Chem. Ber. 90, 601–604(1957)Google Scholar
  138. Lorenz, W., Kusche, J., Barth, H., Mathias, Ch.: Action of several flavonoids on enzymes of histamine metabolism in vitro. In: Histamine. Mechanisms of Regulation of the Biogenic Amines Level in the Tissues With Special Reference to Histamine, Proceedings of Satellite Symposium of the XXVth International Congress of Physiological Sciences, Łodź, Poland 1971, Maslinśki, C. (Ed.)., pp.265–269, Stroudsburg, Penn.: Dowden, Hutchinson & Ross Inc. 1973Google Scholar
  139. Lorenz, D., Marek, M.L.: Das therapeutisch wirksame Prinzip der Roßkastanie (Aesculus hippocastanum). 1. Mitt.: Aufklärung des Wirkstoffes. Arzneimittel-Forsch. 10, 263–272 (1960)Google Scholar
  140. Lorenz, D., Reiffer, F.: Die oedemhemmende Wirksamkeit von Aescin und Buphenin bei cutaner Anwendung am Kaolin-Oedem der Rattenpfote. Arzneimittel-Forsch. 17, 1083–1084 (1967)Google Scholar
  141. Makarov, V.A., Khadzai, Ya.I.: Antiphlogistic and P-vitaminogenic activity of blackthorn flavonols. Farmakol. i Toksikol. 32, 438–441 (1969)Google Scholar
  142. Malawista, S.E.: Colchicine: a common mechanism for its anti-inflammatory and anti-mitotic effects. Arthr. Rheum. 11, 191–197 (1968)Google Scholar
  143. Marrazzi, M.A., Matschinsky, F.M.: Properties of 15-hydroxyprostaglandin dehydrogenase: structural requirements for substrate binding. Prostaglandins 1, 373–388 (1972)PubMedGoogle Scholar
  144. Martin, G.J., Brendel, R., Beiler, J.M.: Effects of parenterally administered trypsin and phosphorylated hesperidin. Arch. int. Pharmacodyn. 96, 124–129 (1953)PubMedGoogle Scholar
  145. Martin, G.J., Graff, M., Brendel, R., Beiler, J.M.: Effect of vitamin P compounds on the action of histidine decarboxylase. Arch. Biochem. 21, 177–180 (1949)PubMedGoogle Scholar
  146. Maslinsky, C., Ed.: Histamine. Mechanisms of Regulation of the Biogenic Amines Level in the Tissues With Special Reference to Histamine, Proceedings Satellite Symposium of the XXVth International Congress of Physiological Sciences, Łódź, Poland 1971. Stroudsburg, Penn.: Dowden, Hutchinson & Ross Inc. 1973Google Scholar
  147. Menkin, V.: Effect of adrenal cortex extract on capillary permeability. Amer. J. Physiol. 129, 691–697(1940)Google Scholar
  148. Menkin, V.: Anti-inflammatory activity of some water-soluble bioflavonoids. Amer. J. Physiol. 196, 1205–1210(1959)PubMedGoogle Scholar
  149. Meyer, R., Schuler, W., Desaulles, P.: Zur Frage des Mechanismus der Hemmung des Bindege-webswachstums durch Cortisone. Experientia (Basel) 6, 469–471 (1950)Google Scholar
  150. Mirkovitch, V., Borgeaud, J., Meyer, S., Niebes, P.: Prévention de thrombose expérimentale par O-(β-hydroxyéthyl)-rutosides. Helv. chir. Acta 39, 379–382 (1972)PubMedGoogle Scholar
  151. Niebes, P.: Influence des flavonoïdes sur la métabolisme des mucopolysaccharides dans la paroi veineuse. In: Comèl, M., Laszt, L. (Eds.): Symposia Angiologica Santoriana, 4th International Symposium, Fribourg-Nyon, Clinical Pharmacology: Flavonoids and Vascular Wall, pp. 94–102. Basel-München-Paris-New York-Sydney: Karger 1972Google Scholar
  152. Niebes, P., Ponard, G.: Stabilization of rat liver lysosomes by (+)-cyanidanol-3 in vivo. Biochem. Pharmacol. 24, 905–909 (1975)PubMedGoogle Scholar
  153. Northover, B.J., Subramanian, G.: A study of possible mediators of inflammatory reactions in the mouse foot. Brit. J. Pharmacol. 18, 346–355 (1962)PubMedGoogle Scholar
  154. Oettel, H., Wilhelm-Kollmansperger, G.: Zur Frage der antiphlogistischen Wirkung von Azulenen. I. Mitteilung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 226, 473–485 (1955)Google Scholar
  155. Oettel, H., Wilhelm-Kollmansperger, G.: Zur Frage der antiphlogistischen Wirkung von Azulenen. II. Mitteilung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 228, 331–339 (1956)Google Scholar
  156. Park, M.K., Dyer, D.C.: Effect of polyphloretinphosphate and 7-oxa-13 prostynoic acid on the vasoactive actions of prostaglandin E2 and 5-hydroxytryptamine on isolated human umbilical arteries. Prostaglandins 3, 913–920 (1973)PubMedGoogle Scholar
  157. Parmar, N.S., Ghosh, M.N.: Some pharmacological studies of bioflavonoids in rats. Bull. Jipmer clin. Soc.10, 183–190(1974)Google Scholar
  158. Pastan, J., Almqvist, S.: Purification and properties of mast cell protease. J. biol. Chem. 241, 5090–5094 (1966)PubMedGoogle Scholar
  159. Patt, P., Winkler, W.: Das therapeutisch wirksame Prinzip der Roßkastanie (Aesculus hippocastanum). 2. Mitt: Zur Chemie des Wirkstoffes. Arzneimittel-Forsch. 10, 273–275 (1960)Google Scholar
  160. Piller, N.B.: The resolution of thermal oedema at various temperatures under coumarin treatment. Brit. J. exp. Path. 56, 83–91 (1975)PubMedGoogle Scholar
  161. Piller, N.B.: An integration of the modes of action of coumarin. An explanation of its effectiveness as a therapy for thermally injured tissue. Arzneimittel-Forsch. (Drug Res.) 27, 1135–1138 (1977 a)Google Scholar
  162. Piller, N.B.: Benzopyrone treatment of mild thermal oedema: determination of the most effective doses. Arzneimittel-Forsch. (Drug Res.) 27, 1138–1141 (1977b)Google Scholar
  163. Poethke, W., Bulin, P.: Phytochemische Untersuchung einer neue gezüchteten Kamillensorte. 1. Mitt.: Flavonglykoside und Cumarinderivate. Pharm. Zentralh. 108, 733–746 (1969a)Google Scholar
  164. Poethke, W., Bulin, P.: Phytochemische Untersuchung einer neu gezüchteten Kamillensorte. 2. Mitt.: Ätherisches Öl. Pharm. Zentralh. 108, 813–823 (1969b)Google Scholar
  165. Preziosi, P., Manca, P.: Die Antiödem- und die antiinflammatorische Wirkung von Aescin und ihre Beziehung zur Hypophysen-Nebennieren-Achse. Arzneimittel-Forsch. 15, 404–413 (1965)Google Scholar
  166. Radouco-Thomas, S., Grumbach, P., Nosal, Gl., Radouco-Thomas, C.: Anti-inflammatory effect of trihydroxyethylrutoside assessed in the granuloma pouch. Life Sci. 3, 459–464 (1964)PubMedGoogle Scholar
  167. Ramaswamy, A.S.: Pharmacological action of the biflavonoids from the Gymnosperms with special reference to Ginkgo biloba L. J. med. Ass. 55, 163–165 (1970)Google Scholar
  168. Ramwell, P.W., (Ed.): The Prostaglandins. New York-London: Plenum Press 1973Google Scholar
  169. Ramwell, P., Shaw, J.E., (Eds.): Prostaglandins. Ann. N.Y. Acad. Sci. 180, 1971Google Scholar
  170. Riesterer, L., Jaques, R.: The influence of anti-inflammatory drugs on the development of an experimental traumatic paw oedema in the rat. Pharmacology (Basel) 3, 243–251 (1970)Google Scholar
  171. Rocha e Silva, M.: Histamine. Its Role in Anaphylaxis and Allergy. Springfield, Illinois: Charles C. Thomas 1955Google Scholar
  172. Rocha e Silva, M. (Ed.): Histamine and Anti-Histaminics, Handbook of Experimental Pharmacology. Berlin-Heidelberg-New York: Springer 1966, Vol. XVIII/1Google Scholar
  173. Rocha e Silva, M., Garcia Lerne, J.: Chemical Mediators of the Acute Inflammatory Reaction. Oxford-New York: Pergamon Press 1972Google Scholar
  174. Rothkopf, M., Vogel, G.: Neue Befunde zur Wirksamkeit und zum Wirkungsmechanismus des Roßkastaniensaponins Aescin. Arzneimittel-Forsch. (Drug Res.) 26, 225–235 (1976)Google Scholar
  175. Salgado, E., Green, D.M.: Action of bioflavonoids on inflammation. J. appl. Physiol. 8, 647–650 (1955)Google Scholar
  176. Samuelsson, B., Paoletti, R. (Eds.): Advances in Prostaglandin and Thromboxane Research. New York: Raven Press 1976Google Scholar
  177. Schilcher, H.: Neuere Erkenntnisse bei der Qualitätsbeurteilung von Kamillenblüten bzw. Kamillenöl. Teil 1: Quantitative Gehaltsbestimmung des ätherischen Öles in Flores Chamomillae. Dtsch. Apoth.-Ztg. 112, 1497–1500 (1972)Google Scholar
  178. Schilcher, H.: Neuere Erkenntnisse bei der Qualitätsbeurteilung von Kamillenblüten bzw. Ka-millenöl. Teil 2: Qualitative Beurteilung des ätherischen Öles in Flores Chamomillae. Planta med. 23, 132–144(1973)PubMedGoogle Scholar
  179. Schwabe, K.-P., Flohé, L.: Catechol-O-Methyltransferase, III. Beziehungen zwischen der Struktur von Flavonoiden und deren Eignung als Inhibitoren der Catechol-O-Methyltransferase. Hoppe-Seylers Z. physiol. Chem. 353, 476–482 (1972)PubMedGoogle Scholar
  180. Selye, H.: Use of “Granuloma Pouch” technique in the study of antiphlogistic corticosteroids. Proc. Soc. exp. Biol. (N.Y.) 82, 328–333 (1953)Google Scholar
  181. Sharma, J.N., Sharma,J.N.: Comparison of the anti-inflammatory activity of Commiphora mukul, an indigenous drug, with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittel-Forsch. (Drug Res.) 27, 1455–1457 (1977)Google Scholar
  182. Shils, M.E., Goodhart, R.S.: The Flavonoids in Biology and Medicine. A Critical Review. New York: The National Vitamin Foundation 1956Google Scholar
  183. Shimamoto, K., Takaori, S.: Pharmakologische Untersuchungen mit einem Melilotus-Extrakt. Arzneimittel-Forsch. 15, 897–899 (1965)Google Scholar
  184. Sokoloff, B., Eddy, W.H., Redd, J.B.: The biological activity of a flavonoid (Vitamin “P”) compound. J. clin. Invest. 30, 395–400 (1951)PubMedGoogle Scholar
  185. Somers, G.F.: Glycyrrhetinic acid. Brit. med. J. I, 463 (1957)Google Scholar
  186. Southern, E. M., Ed.: The Prostaglandins. Clinical Applications in Human Reproduction. Mount Kisco, New York: Futura Publ. Co. Inc. 1972Google Scholar
  187. Spector, W.G., Willoughby, D.A.: Chemical mediators. In: The Inflammatory Process, Zweifach, B.W., Grant, L., McCluskey, R.T. (Eds.). New York-London: Academic Press 1965, pp. 427–448Google Scholar
  188. Spector, W.G., Willoughby, D.A.: The Pharmacology of Inflammation. London: English Universities Press 1968Google Scholar
  189. Stern, P.: Antiallergische Wirkung der Azulene. In: Premier Congrês International d’Allergie, Zürich-Basel-New York: Karger 1951, pp.542–545Google Scholar
  190. Stern, P.: Beitrag zur Wirkungsweise der Azulene. Arzneimittel-Forsch. 9, 551–553 (1959)Google Scholar
  191. Stern, P., Milin, R.: Die antiallergische und antiphlogistische Wirkung der Azulene. Arzneimittel-Forsch. 6, 445–450 (1956)Google Scholar
  192. Strandberg, K., Tuvemo, T.: Reduction of the tone of the isolated human umbilical artery by Indomethacin, Eicosa-5,8,11,14-tetraynoic acid and polyphloretin phosphate. Acta physiol. scand. 94, 319–326 (1975)PubMedGoogle Scholar
  193. Tarayre, J.P., Lauressergues, H.: Preuve pharmacologiques de l’activité de l’hespéridine méthyl chalcone. Angéiologie 27, 197–203 (1975)Google Scholar
  194. Tarayre, J.P., Lauressergues, H.: Etude de quelques propriétés pharmacologiques d’une association vasculotrope. Ann. Pharm. Fr. 34, 375–382 (1976)PubMedGoogle Scholar
  195. Tarayre, J.P., Lauressergues, H.: Advantages of a combination of proteolytic enzymes, flavonoids and ascorbic acid in comparison with non-steroid anti-inflammatory agents. Arzneimittel-Forsch. (Drug Res.) 27, 1144–1149 (1977)Google Scholar
  196. Texl, A.: The Effect of Catechol Complexes from Tea Leafs on Experimental Inflammation 19, 515–519(1963)Google Scholar
  197. Thiele, K., Jakovlev, V., Isaac, O., Schuler, W.A.: Äther und von (-)-α-Bisabolol und analogen Mono- und Sesquiterpenoiden mit antiphlogistischer Wirkung. Arzneimittel-Forsch. 19, 1878–1882 (1969)Google Scholar
  198. Thiemer, K., Stadler, R., Isaac, O.: Biochemische Untersuchungen von Kamillen-Inhaltstoffen. II. Einfluß von Kamillenextrakt auf die oxydative Phosphorylierung und den Hautstoffwechsel des Meerschweinchens. Arzneimittel-Forsch. 23, 756–759 (1973)Google Scholar
  199. Uda, T.: The mode of inhibiting action of guaiazulene and some other antiinflammatory agents on anaphylactoid edemas. Nippon Yakurigaku Zasshi 56, 1151–1163 (1960). See Chem. Abst. 56, 4058h (1962)Google Scholar
  200. Van Caneghem, P.: Influence of some hydrosoluble substances with vitamin P activity on the fragility of lysosomes in vitro. Biochem. Pharmacol. 21, 1543–1548 (1972)PubMedGoogle Scholar
  201. Van Cauwenberge, H., Franchimont, P.: Action du Z 6000 (trihydroxyethylrutoside) sur divers tests d’inflammation expérimentale réalisés chez le rat. Arch. int. Pharmacodyn. 170, 74–80 (1967)PubMedGoogle Scholar
  202. Van Cauwenberge, H., Franchimont, P.: Untersuchung der antiphlogistischen Eigenschaften von Trihydroxyäthylrutosid. Zbl. Phlebol. 7,110–121 (1968)PubMedGoogle Scholar
  203. Van Cauwenberge, H., Lecomte, J., Cession-Fossion, A.: Sur quelques activités pharmacologiques de la (+)-catechine chez le rat. CR. Soc. Biol. (Paris) 165, 1195–1198 (1971)Google Scholar
  204. Van Cauwenberge, H., Lecomte, J., Franchimont, P.: De la recherche expérimentale à la recherche clinique dans le domaine des affections capillaro-veineuses. Vie méd. 50, 108–116 (1969)Google Scholar
  205. Vane, J.R.: Prostaglandins in the inflammatory response. In: Lepow, J.-H., Ward, P.A. (Eds.): Inflammation Mechanisms and Control, pp.261–279. London: Academic Press 1972Google Scholar
  206. Vane, J.R.: Prostaglandins as mediators of inflammation. In: Samuelsson, B., Paoletti, R. (Eds.): Advances in Prostaglandin and Thromboxane Research, pp.791–801. New York: Raven Press 1976Google Scholar
  207. Villanueva, R., Hinds, L., Katz, R.L., Eakins, K.E.: The effect of polyphloretin phosphate on smooth muscle actions of prostaglandins in the cat. J. Pharmacol. exp. Ther. 180, 78–85 (1972)PubMedGoogle Scholar
  208. Vogel, G., Marek, M.L.: Rattenpfoten-Ödem durch Polyvinylpyrrolidon und seine pharmakologische Beeinflußbarkeit. Eine einfache Methode zur Beurteilung der Kapillarpermeabilität für Flüssigkeit und definierte Makromoleküle. Arzneimittel-Forsch. 11, 356–362 (1961)Google Scholar
  209. Vogel, G., Marek, M.L., Oertner, R.: Untersuchungen zum Mechanismus der therapeutischen und toxischen Wirkung des Roßkastanien-Saponins Aescin. Arzneimittel-Forsch. 20, 699–703 (1970)Google Scholar
  210. Vogel, G., Marek, M.L., Stoeckert, I.: Weitere Untersuchungen zum Wirkungsmechanismus des Roßkastanien-Saponins Aescin. Arzneimittel-Forsch. 13, 59–64 (1963)Google Scholar
  211. Vogel, G., Uebel,H.: Das therapeutisch wirksame Prinzip der Roßkastanie (Aesculus hippocastanum). 3. Mitt: Zur Frage von Angriffspunkt und Wirkungsmechanismus. Arzneimittel-Forsch. 10, 275–280 (1960)Google Scholar
  212. Vogin, E.E., Rossi, G.V.: Radiometrie quantitation of the inhibition of 5-hydroxytryptamine-induced edema in mice. Arch. int. Pharmacodyn. 144, 151–160 (1963)PubMedGoogle Scholar
  213. Weissmann, G.: The role of lysosomes in inflammation and disease. Ann. Rev. Med. 18, 97–112 (1967)PubMedGoogle Scholar
  214. Whitehouse, M.W.: Some biochemical and pharmacological properties of anti-inflammatory drugs. In: Jucker, E. (Ed.): Progress in Drug Research, Vol.VIII, pp.321–429. Basel-Stuttgart: Birkhäuser 1965Google Scholar
  215. Wilhelm, D.L.: Chemical Mediators. In: Zweifach, B.W., Grant, L., McCluskey, R.T. (Eds.): The Inflammatory Process, pp. 389–425. New York-London: Academic Press 1965Google Scholar
  216. Wilhelm, D.L.: Chemical Mediators,In: Zweifach, B.W., Grant, L., McCluskey, R.T. (Eds.): The Inflammatory Process, Vol.11, pp.251–301. New York-London: Academic Press 1973Google Scholar
  217. Williams, T.J., Morley, J.: Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature (Lond.) 246, 215–217 (1973)Google Scholar
  218. Winder, C.V., Wax, J., Burr, V., Been, M., Rosière, C.E.: A study of pharmacological influences on ultraviolet erythema in guinea pigs. Arch. int. Pharmacodyn. 116, 261–292 (1958)PubMedGoogle Scholar
  219. Winter, G.A.: Nonsteroid antiinflammatory agents. In: Jucker, E. (Ed.): Progress in Drug Research, Vol. 10, pp. 139–203. Basel-Stuttgart: Birkhäuser 1966aGoogle Scholar
  220. Winter, C.A.: Nonsteroid anti-inflammatory agents. Ann. Rev. Pharmacol. 6, 157–174 (1966b)PubMedGoogle Scholar
  221. Wolstenholme, G.E.W., O’Connor, C.M., (Eds.): Histamine. CIBA Foundation Symposium. London: J. & A. Churchill Ltd 1956Google Scholar
  222. Yamasaki, H., Irino, S., Saito, N., Kondo, K., Jinzenji, K., Yamamoto, T.: Pharmacology of guaiazulene with special reference to anti-inflammatory effect due to inhibition of histamine release. Nippon Yakurigaku Zasshi 54, 362–377 (1958). See Chem. Abst. 53, 10525d (1959)Google Scholar
  223. Yegnanarayan, R., Saraf, A.P., Balwani, J.H.: Comparison of anti-inflammatory activity of various extracts of Curcuma longa. Linn. Indian J. Med. Res. 64, 601–608 (1976)Google Scholar
  224. Zierz, P., Lehmann, A., Craemer, R.: Die Beeinflußbarkeit akuter Entzündungsvorgänge durch Azulene. Hautarzt 8, 552–556 (1957)PubMedGoogle Scholar
  225. Zweifach, B.W., Grant, L., McCluskey, R.T.: The Inflammatory Process, 2nd Ed., New York-London: Academic Press 1973, Vol.11Google Scholar
  226. Zweig, M.H., Maling, H.M., Webster, M.E.: Inhibition of sodium urate-induced rat hindpaw edema by colchicine derivatives: correlation with antimitotic activity. J. Pharmacol. exp. Ther. 182, 344–350(1972)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • M. Gábor

There are no affiliations available

Personalised recommendations